Fundraising Fox

Vianovatx

2 known investors

vianovatx.com ↗

Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.

BiotechDigital HealthMedical Devices

Founders & leadership

DG
Donald GanemExecutive Officer, Director
JJ
Joseph JimenezDirector
BL
Benjamine LiuDirector
IZ
Ilan ZipkinDirector

Investors · 2

Aditum BioOakland
PMVBrussels

Reported raises · per SEC filings

Form D private placements
▶$5MraisedSep 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald GanemExecutive Officer, Director
  • Joseph JimenezDirector
  • Benjamine LiuDirector
  • Ilan ZipkinDirector
Offering amount
$5M
Amount sold
$5M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.